cell and gene therapy world


Meet the Future of Cell & Gene Therapy

The world’s only whole-ecosystem partnering event for the cell & gene therapy industry

Influential global meeting for Advanced Therapies

Phacilitate Cell & Gene Therapy World is the biggest and most influential global meeting for Advanced Therapies. Meet more decision makers in 4 days than you can in 4 months in the normal run of business! 1,500+ attendees, 200+ speakers, 100+ exhibitors – it is the one meeting on the global calendar attended by all of the critical decision-makers from both inside and outside of the cell & gene therapy industry.

 Largest, most immersive Expo

The world’s largest, most immersive Expo for cell & gene therapy. Phacilitate Miami delivers the largest dedicated cell & gene therapy exhibition featuring the most innovative solution providers (In total we had 100+ exhibitors). Experience a unique blend of live show floor content, interactive journeys through our Hubs, plus entertainment and networking of the highest quality. All the key solution providers driving efficient R&D and commercial scale manufacturing will provide practical, interactive demonstrations of their capabilities in a living, breathing exhibition area.

Key voices defining commercial success

More decision makers than any other cell & gene therapy event, representing all the key voices defining commercial success. Meet more leaders representing not just the cell & gene therapy biotech sector, but the world’s leading regulators, HTAs and payers, plus investors and big pharma. New and expanded initiatives such as the Super Plenary and CEO Forum ensure attendees of a breadth and level of influence never before seen at an event for this sector.

But also more hands-on implementers!

…But also more hands-on implementers! We don’t just deliver the ultimate decision makers… Phacilitate fully recognises the importance of insights from and contact with more ‘hands-on’, technically-minded personnel from pharma, biotech and academia.

Fun, effective networking

Setting a brand new standard for fun, effective networking. From themed cocktail receptions on the banks of the Miami Canals through our Japan Partnering Lunch to the already-legendary Phacilitate Miami Yacht Party, Phacilitate Leaders Forum 2018 will support your partnering activities like never before.

Genuine MUST attend

Cell & Gene Therapy World is a genuine MUST attend. Total event score by AMR International including delegates and sponsors was 4.5/5 (VERY GOOD/EXCELLENT)

Coverage on functional & technology areas

The only event that offers both dedicated coverage focused specifically on functional and technology areas, whilst also placing these components in their wider strategic context at the core of successful cell & gene therapy business and commercialization models.

Co-location with I-O Frontiers World

Meet the whole eco-system of immuno-oncology through colocation with I-O Frontiers. Access a wider audience of potential clients and meet partners seeking to hone their immuno-oncology combination development strategies and/or enter the cellular immunotherapy arena.

Calling all tool and service providers!


  • Phacilitate Cell & Gene Therapy is the best cell & gene therapy lead generation event in the world. Phacilitate is the leading partnering event in the industry according to independent research by AMR International. Sponsors rated Phacilitate Miami 2017 as the best event to generate high quality leads. (NPS: +73) https://en.wikipedia.org/wiki/Net_Promoter     
  • We guarantee that you will be able to establish relationships with both ultimate decision makers and implementers/influencers under one roof.
  • Educate emerging biotechs yet to select their preferred suppliers. Phacilitate Cell & Gene Therapy World will deliver more early stage, emerging biotech companies than any other partnering event for the sector.
  • Phacilitate is the only event to truly support industry/academic convergence. Meet both industry and scientific KOLs under 1 roof. This means that companies can save thousands on their marketing and business development budgets!
  • Strike while the iron is hot! Ride the wave of investor and pharma fervour following 2017s expected landmark US product approvals and set the tone for your business in 2018!
  • Phacilitate is the first port of call for new arrivals in the cell & gene therapy space seeking solutions. The cell & gene therapy sector is expanding at an unprecedented rate and its ranks are being swollen on a daily basis by scientists, technicians and executives from across the life sciences, and even further afield. Be one of the first solution providers they will meet in person at Phacilitate Miami!

  • "The event reflected the fantastic growing enthusiasm around cell and gene therapy, including small and large companies, investors and regulators. It was great to see everyone so engaged and so positive. The event really gives you the “pulse” of what is happening right now in cell and gene therapy."
    Anne-Virginie Eggimann,
  • “Great program, great people, great venue.”
    Klaus Kühlcke
    Managing Director, EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.”
    Nathalie Clement
    Associate Director, Powell Gene Therapy Center, University of Florida
  • "Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
    Dr James Trager
    Vice President, Research & Product Development, Dendreon
  • "It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives."
    Kurt Gielen
    Acquisition & Business Development Manager, BioMedical Materials, Chemelot Campus B.V.
  • “Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.”
    Steven Goodman
    Director, Strategy and Engagement, GSK